Cases 31 - 40 of 262
Pfizer Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2022cv00192
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00221
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00083
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00092
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc.
as 1:2021cv01619
Plaintiff:
Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH and Cephalon, Inc.
Defendant:
Hospira, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Development, Inc. et al
as 1:2021cv01353
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Lotus Pharmaceutical Co., Ltd. et al
as 1:2021cv01107
Plaintiff:
Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant:
Lotus Pharmaceutical Co., Ltd. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 1
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc.
as 1:2021cv01001
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
